vs
Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and AVIENT CORP (AVNT). Click either name above to swap in a different company.
Alignment Healthcare, Inc. is the larger business by last-quarter revenue ($1.0B vs $760.6M, roughly 1.3× AVIENT CORP). AVIENT CORP runs the higher net margin — 2.2% vs -1.1%, a 3.3% gap on every dollar of revenue. On growth, Alignment Healthcare, Inc. posted the faster year-over-year revenue change (44.4% vs 1.9%). AVIENT CORP produced more free cash flow last quarter ($125.4M vs $-55.4M). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (26.9% CAGR vs -4.2%).
Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.
Avient Corporation is a global materials solutions company headquartered in Avon Lake, Ohio, United States, employing approximately 9,000 people worldwide. Its products include colorants, advanced composites, functional additives and engineered materials.
ALHC vs AVNT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.0B | $760.6M |
| Net Profit | $-11.0M | $16.9M |
| Gross Margin | — | 30.2% |
| Operating Margin | -1.0% | 5.2% |
| Net Margin | -1.1% | 2.2% |
| Revenue YoY | 44.4% | 1.9% |
| Net Profit YoY | 64.6% | -65.0% |
| EPS (diluted) | $-0.04 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.0B | $760.6M | ||
| Q3 25 | $993.7M | $806.5M | ||
| Q2 25 | $1.0B | $866.5M | ||
| Q1 25 | $926.9M | $826.6M | ||
| Q4 24 | $701.2M | $746.5M | ||
| Q3 24 | $692.4M | $815.2M | ||
| Q2 24 | $681.3M | $849.7M | ||
| Q1 24 | $628.6M | $829.0M |
| Q4 25 | $-11.0M | $16.9M | ||
| Q3 25 | $3.7M | $32.6M | ||
| Q2 25 | $15.7M | $52.6M | ||
| Q1 25 | $-9.1M | $-20.2M | ||
| Q4 24 | $-31.1M | $48.3M | ||
| Q3 24 | $-26.4M | $38.2M | ||
| Q2 24 | $-24.0M | $33.6M | ||
| Q1 24 | $-46.5M | $49.4M |
| Q4 25 | — | 30.2% | ||
| Q3 25 | — | 30.4% | ||
| Q2 25 | — | 32.1% | ||
| Q1 25 | — | 31.8% | ||
| Q4 24 | — | 34.8% | ||
| Q3 24 | — | 32.1% | ||
| Q2 24 | — | 30.3% | ||
| Q1 24 | — | 33.6% |
| Q4 25 | -1.0% | 5.2% | ||
| Q3 25 | 0.8% | 8.3% | ||
| Q2 25 | 2.2% | 11.1% | ||
| Q1 25 | -0.6% | 0.1% | ||
| Q4 24 | -3.2% | 11.5% | ||
| Q3 24 | -2.8% | 9.5% | ||
| Q2 24 | -2.7% | 8.5% | ||
| Q1 24 | -6.5% | 11.3% |
| Q4 25 | -1.1% | 2.2% | ||
| Q3 25 | 0.4% | 4.0% | ||
| Q2 25 | 1.5% | 6.1% | ||
| Q1 25 | -1.0% | -2.4% | ||
| Q4 24 | -4.4% | 6.5% | ||
| Q3 24 | -3.8% | 4.7% | ||
| Q2 24 | -3.5% | 4.0% | ||
| Q1 24 | -7.4% | 6.0% |
| Q4 25 | $-0.04 | $0.18 | ||
| Q3 25 | $0.02 | $0.36 | ||
| Q2 25 | $0.07 | $0.57 | ||
| Q1 25 | $-0.05 | $-0.22 | ||
| Q4 24 | $-0.15 | $0.53 | ||
| Q3 24 | $-0.14 | $0.41 | ||
| Q2 24 | $-0.13 | $0.36 | ||
| Q1 24 | $-0.25 | $0.54 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $604.2M | — |
| Total DebtLower is stronger | $323.2M | $1.9B |
| Stockholders' EquityBook value | $179.3M | $2.4B |
| Total Assets | $1.1B | $6.0B |
| Debt / EquityLower = less leverage | 1.80× | 0.81× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $604.2M | — | ||
| Q3 25 | $644.1M | — | ||
| Q2 25 | $503.8M | — | ||
| Q1 25 | $479.5M | — | ||
| Q4 24 | $470.6M | — | ||
| Q3 24 | $381.0M | — | ||
| Q2 24 | $363.7M | — | ||
| Q1 24 | $301.7M | — |
| Q4 25 | $323.2M | $1.9B | ||
| Q3 25 | $322.7M | $2.0B | ||
| Q2 25 | $322.3M | $2.0B | ||
| Q1 25 | $321.9M | $2.1B | ||
| Q4 24 | $321.4M | $2.1B | ||
| Q3 24 | $212.0M | $2.1B | ||
| Q2 24 | $211.7M | $2.1B | ||
| Q1 24 | $162.0M | $2.1B |
| Q4 25 | $179.3M | $2.4B | ||
| Q3 25 | $161.9M | $2.4B | ||
| Q2 25 | $141.0M | $2.4B | ||
| Q1 25 | $108.1M | $2.3B | ||
| Q4 24 | $99.9M | $2.3B | ||
| Q3 24 | $114.5M | $2.4B | ||
| Q2 24 | $123.7M | $2.3B | ||
| Q1 24 | $130.9M | $2.3B |
| Q4 25 | $1.1B | $6.0B | ||
| Q3 25 | $1.1B | $6.1B | ||
| Q2 25 | $1.0B | $6.1B | ||
| Q1 25 | $895.6M | $5.8B | ||
| Q4 24 | $782.1M | $5.8B | ||
| Q3 24 | $692.3M | $6.0B | ||
| Q2 24 | $716.3M | $5.9B | ||
| Q1 24 | $633.2M | $5.9B |
| Q4 25 | 1.80× | 0.81× | ||
| Q3 25 | 1.99× | 0.83× | ||
| Q2 25 | 2.29× | 0.86× | ||
| Q1 25 | 2.98× | 0.90× | ||
| Q4 24 | 3.22× | 0.89× | ||
| Q3 24 | 1.85× | 0.88× | ||
| Q2 24 | 1.71× | 0.90× | ||
| Q1 24 | 1.24× | 0.90× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-50.4M | $167.8M |
| Free Cash FlowOCF − Capex | $-55.4M | $125.4M |
| FCF MarginFCF / Revenue | -5.5% | 16.5% |
| Capex IntensityCapex / Revenue | 0.5% | 5.6% |
| Cash ConversionOCF / Net Profit | — | 9.93× |
| TTM Free Cash FlowTrailing 4 quarters | $113.1M | $195.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-50.4M | $167.8M | ||
| Q3 25 | $144.6M | $72.1M | ||
| Q2 25 | $29.1M | $112.8M | ||
| Q1 25 | $16.6M | $-51.1M | ||
| Q4 24 | $-8.7M | $122.6M | ||
| Q3 24 | $26.2M | $71.1M | ||
| Q2 24 | $23.5M | $105.9M | ||
| Q1 24 | $-6.2M | $-42.8M |
| Q4 25 | $-55.4M | $125.4M | ||
| Q3 25 | $139.1M | $47.4M | ||
| Q2 25 | $21.1M | $85.8M | ||
| Q1 25 | $8.4M | $-63.6M | ||
| Q4 24 | $-18.0M | $81.5M | ||
| Q3 24 | $16.9M | $46.1M | ||
| Q2 24 | $11.8M | $74.5M | ||
| Q1 24 | $-17.4M | $-67.2M |
| Q4 25 | -5.5% | 16.5% | ||
| Q3 25 | 14.0% | 5.9% | ||
| Q2 25 | 2.1% | 9.9% | ||
| Q1 25 | 0.9% | -7.7% | ||
| Q4 24 | -2.6% | 10.9% | ||
| Q3 24 | 2.4% | 5.7% | ||
| Q2 24 | 1.7% | 8.8% | ||
| Q1 24 | -2.8% | -8.1% |
| Q4 25 | 0.5% | 5.6% | ||
| Q3 25 | 0.6% | 3.1% | ||
| Q2 25 | 0.8% | 3.1% | ||
| Q1 25 | 0.9% | 1.5% | ||
| Q4 24 | 1.3% | 5.5% | ||
| Q3 24 | 1.3% | 3.1% | ||
| Q2 24 | 1.7% | 3.7% | ||
| Q1 24 | 1.8% | 2.9% |
| Q4 25 | — | 9.93× | ||
| Q3 25 | 38.77× | 2.21× | ||
| Q2 25 | 1.86× | 2.14× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 2.54× | ||
| Q3 24 | — | 1.86× | ||
| Q2 24 | — | 3.15× | ||
| Q1 24 | — | -0.87× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALHC
Segment breakdown not available.
AVNT
| Color Additives And Inks | $466.0M | 61% |
| Specialty Engineered Materials | $295.5M | 39% |
